Skip to main navigation
Contact Us
EN
Search:
Toggle Navigation
Search:
EN
Main navigation
About Us
Our Company
Management Team
Board of Directors
Clinical Advisory Boards
Contact Us
Pipeline
BLU-5937
Chronic Cough
Chronic Pruritus
Clinical Trials
Science
P2X3 Inhibition
Scientific Publications
Investors & Media
Investors Home
Press Releases
Events & Presentations
Financial Reports & Other
SEC Filings
Other Filings
Stock Information
Stock Quote & Chart
Analyst Coverage
Corporate Governance
Documents & Charters
Management
Board of Directors
Clinical Advisory Boards
Committee Composition
Investor Resources
Investor Contact
FAQs
Email Alerts
Investors & Media
Event Details
«
Back
BLU-5937 Phase 1 Data and Corporate Update
11/20/18
Supporting Materials
BLU-5937 Phase 1 Data and Corporate Update
256.2 KB
